Enervit S.p.a.MIL: ENV

Enervit SpA: The Board of Directors approves the Draft Financial Statements and the Consolidated Financial Statements as at 31 December 2025

· Issued by Enervit S.p.A.
PRESS RELEASE - Enervit S.p.A. Revenues exceed €100 million EBITDA and Net Profit on the rise The Board of Directors approves the Draft Annual Financial Statements and the Consolidated Financial Statements as at 31 December 2025 Milan, 12 March 2026 - The Board of Directors of Enervit S.p.A., a company active in the sports nutrition and functional nutrition markets through research, development, production, and commercialisation of foods and supplements for sportspeople and wellness-conscious consumers, today approved the Draft Annual Financial Statements of Enervit S.p.A. for the year ended 31 December 2025, and approved the Consolidated Financial Statements of the Enervit Group for the year ended 31 December 2025. A dividend distribution of €0.215 per share (gross of statutory withholding taxes) has been proposed, payable as from 20 May 2026, with record date 19 May 2026 and ex-dividend date 18 May 2026. The Shareholders' Meeting has been convened for 28 April 2026.

Key consolidated results as at 31 December 2025

  • Revenues: €103.2 million (vs. €96.7 million as at 31 December 2024);
  • EBITDA: €10.0 million (vs. €9.5 million as at 31 December 2024);
  • EBIT: €6.1 million (vs. €5.5 million as at 31 December 2024);
  • Net profit: €4.3 million (vs. €4.1 million as at 31 December 2024);
  • Net Financial Position: positive €2.4 million (vs. a positive €1.0 million as at 31 December 2024), reflecting the distribution of €2.8 million in dividends. Consolidated results as at 31 December 2025

    As at 31 December 2025, the Enervit Group recorded revenues of €103.2 million, up 6.7% compared

    to the €96.7 million reported in the same period of 2024.

    This performance reflects a positive trend across all business areas. Italy - representing 74.6% of total revenues - reported growth of 2.6%.

    International markets, accounting for 13.1% of total revenues, grew by 12.5% compared to 2024.

    The Contract Manufacturing channel, with a 2.4% share of total revenues, also increased by 3.7% compared with 2024.

    Finally, the Direct channel, driven by online sales and representing 10.0% of total revenues, grew by 40.6% compared with the same period in 2024.

    As at 31 December 2025, EBITDA amounted to €10.0 million, up 5.1% year-on-year (2024: €9.5

    million).

    EBIT totalled €6.1 million, an increase of 9.8% compared with the €5.5 million recorded in 2024.

    The Enervit Group recorded a Net Profit of €4.3 million, up 3.2% compared with €4.1 million in

    2024.

    The Net Financial Position as at 31 December 2025 was positive €2.4 million, an improvement compared with the positive €1.0 million recorded in 2024.

    Other resolutions

    The Board of Directors of Enervit S.p.A. also:

  • approved the Corporate Governance and Ownership Structure Report, drafted pursuant to Art. 123-bis of the TUF, and the Remuneration Report drafted pursuant to Art. 123-ter of the TUF;

  • proposed the distribution of a dividend of €0.215 per share (gross), payable as from 20 May

    2026, with record date 19 May 2026 and ex-dividend date 18 May 2026;

  • resolved to convene the Ordinary Shareholders' Meeting, in a single call, exclusively via

    telecommunication means, for 28 April 2026 at 11:00 a.m., with the following agenda:

    1. Approval of the Annual Financial Statements as at 31 December 2025; Directors' Report on Operations for the 2025 financial year; Report of the Board of Statutory Auditors; Report of the Independent Auditors. Presentation of the Consolidated Financial Statements of the Enervit Group as at 31 December 2025. Related and consequent resolutions.

    2. Resolutions regarding the allocation of the 2025 financial year result.

    3. Report on the Remuneration Policy and on the remuneration paid:

      1. approval of the Remuneration Policy pursuant to Art. 123-ter, paragraph 3-ter, of Legislative Decree no. 58/1998;

      2. resolutions on the "second section" of the report, pursuant to Art. 123-ter, paragraph 6, of Legislative Decree no. 58/1998.

    4. Appointment of the Board of Directors: (4.1) Determination of the number of members; (4.2) Determination of the term of office; (4.3) Appointment of the members of the Board of Directors; (4.4) Appointment of the Chair; (4.5) Determination of remuneration of the members of the Board of Directors.

    5. Appointment of the Board of Statutory Auditors for the 2023-2025 term: (5.1) Appointment of the members; (5.2) Appointment of the Chair; (5.3) Determination of their remuneration.

Pursuant to Art. 135-undecies.1 of Legislative Decree no. 58/1998 ("TUF") and Articles 8 and 9 of the Articles of Association, the Company has decided to require that shareholders attend the Meeting exclusively through the Designated Representative, as provided for under Art. 135-undecies of the TUF.

Those legally entitled to attend may participate only via telecommunication means, pursuant to Article 8 of the Articles of Association, using the procedures that will be communicated by the Company to the relevant parties.

***

The Draft Annual Financial Statements as at 31 December 2025, together with the Management Report, the Directors' Reports on the items on the agenda of the Shareholders' Meeting, the Report of the Board of Statutory Auditors and the Report of the Independent Auditors, will be made available to the public at the Company's registered office and on the Company's website - https://www.enervit.com, in the "Investor Relations" section, within the statutory deadlines.

***

The Executive in charge of preparing the corporate accounting documents of Enervit S.p.A., Dr Giuseppe Raciti, declares - pursuant to Art. 154-bis, paragraph 2 of Legislative Decree 58/1998 -that the accounting information contained in this press release corresponds to documentary evidence, books and accounting records.

***

Enervit S.p.A.

Enervit - The Positive Nutrition Company - operates in the sports nutrition and functional nutrition sectors through the research, development, production, and commercialisation of foods and supplements for sportspeople and individuals focused on wellness and fitness. Enervit S.p.A. promotes the culture of positive nutrition combined with the value of regular physical activity and is committed to acting in respect of the environment, people, and the community, contributing credibly to a sustainable transition.

The entire production process, from ideation to testing, from development to manufacturing, is carried out at the facilities in Zelbio (CO) and Erba (CO) to ensure the highest level of quality. The Company is certified UNI EN ISO 9001, UNI EN ISO 14001 and BRC.

The Group has 254 employees and generated €103.2 million in revenues as at 31 December 2025

across four sales channels: Italy, International, Contract Manufacturing and Direct.

***

For further information: Enervit S.p.A. - Media Relations

Matilde Pozzi

Tel: +39 02 48563 (1)

Email: m.pozzi@enervit.com - ufficiostampa@enervit.com

Asat31EhmemberAW5emd3lDmembm2DZ4











Buidùaga



Irxlustrial and czxzaz+mÒal equi I

207,243







Ftitgbt-of-+iaa aasets - PPE {IFR6 16}

2.843, 16







PPE urder corednxtiou and w:ivancea





574,246





¥.Z07.778 1$5¥4.7Z9



440,210

S83.489



547,317

750.47J









3,84& s.1y8











Inventc¥wa

¥1 77,716



1$1éJ§'.D85







1.608,717







Caah re+d caeh eqzùvaJarrla



¥1.8O7,515 é7 1,439





TOTAL AbSET6

7D.107,Z02



As alJJ Dacarrz›ac 202s ano 31 Decnmber 2024



















dB 1

m,ma































2,S94.T51









+aa‹›e

«,›xss









TOTAL EQUBTY



sz













2.145























ToL¥I nR I¥erit ¥B Ilbea





































TOTAL LfABlLlTlE9



er le I

Company analysis

Earlier from Enervit

All Enervit news releases